Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The drug targets three receptors involved in energy balance and metabolism: GLP-1 (glucagon-like peptide-1) receptor GIP (glucose-dependent insulinotropic polypeptide) receptor Glucagon receptor By activating these pathways, the therapy aims to: Reduce appetite Improve insulin regulation Increase metabolic activity and energy expenditure This triple-receptor mechanism distinguishes retatrutide from earlier metabolic drugs that target only one or two pathways
These analyses focus on transcriptional regulation and protein synthesis mechanisms associated with receptor activation
Retrieved from SingleCare
Regular resistance training, a high-protein diet, and tracking your nutrition can help preserve muscle and make weight loss more sustainable, whether you are on a GLP-1 or not
